Kidiamix G

Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, the active ingredient in Kidiamix G, is an amino acid supplement presented as a parenteral solution for intravenous use. It is intended to support patients with increased protein and amino‑acid requirements, such as those recovering from surgery or experiencing malnutrition.

GNH USA supplies Kidiamix G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidiamix G provides a balanced mixture of essential and non‑essential amino acids that can be used in clinical situations where protein synthesis needs support. - Protein‑energy malnutrition: helps restore nitrogen balance and promote tissue repair. - Post‑operative recovery: supplies amino acids needed for wound healing and muscle rebuilding. - Metabolic disorders with amino‑acid deficiency: assists in correcting specific deficits and stabilising metabolic pathways.

Kidiamix G is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the infusion site. - Nausea: transient feeling of queasiness. - Headache: mild to moderate intensity. - Transient hypernatremia: slight increase in serum sodium. - Mild metabolic alkalosis: temporary shift in acid‑base balance. - Flushing: brief warmth or redness of skin.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate medical attention. - Severe hypernatremia: marked elevation of serum sodium levels. - Acute renal dysfunction: sudden decline in kidney function. - Metabolic acidosis: significant disturbance in acid‑base status. - Thrombophlebitis: inflammation of a vein with clot formation. - Seizures: rare neurologic events linked to electrolyte shifts.

Kidiamix G should be administered under medical supervision with attention to patient-specific factors. - Renal impairment: monitor renal function and adjust infusion rate if needed. - Hepatic dysfunction: assess liver enzymes before and during therapy. - Electrolyte disorders: correct existing imbalances prior to infusion. - Pregnancy and lactation: use only if clearly indicated and benefits outweigh risks. - Concomitant nutrition therapy: coordinate with other parenteral or enteral nutrition regimens. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G may interact with other agents that affect amino‑acid metabolism or fluid balance.

Major Interactions (Avoid): - High‑dose insulin therapy: may exacerbate hypoglycaemia due to increased amino‑acid uptake. - Loop diuretics: can intensify electrolyte disturbances when combined with amino‑acid solutions.

Moderate Interactions (Monitor Closely): - Renal‑active drugs (e.g., ACE inhibitors): watch for changes in serum creatinine. - Other parenteral nutrition products: avoid overlapping amino‑acid provision to prevent excess load. - Anticonvulsants (e.g., valproate): monitor for altered plasma amino‑acid levels.